127 related articles for article (PubMed ID: 3581060)
1. Comparison of in vivo and in vitro effects of continuous exposure of L1210 cells to 6-thioguanine.
Maybaum J; Morgans CW; Hink LA
Cancer Res; 1987 Jun; 47(12):3083-7. PubMed ID: 3581060
[TBL] [Abstract][Full Text] [Related]
2. Comparison of in vitro and in vivo effects of thymidine on L1210 leukemia in mice.
Zaharko DS; Ramonas LM
J Natl Cancer Inst; 1982 May; 68(5):875-80. PubMed ID: 6951095
[TBL] [Abstract][Full Text] [Related]
3. A pediatric phase I trial and pharmacokinetic study of thioguanine administered by continuous i.v. infusion.
Kitchen BJ; Balis FM; Poplack DG; O'Brien M; Craig CE; Adamson PC
Clin Cancer Res; 1997 May; 3(5):713-7. PubMed ID: 9815740
[TBL] [Abstract][Full Text] [Related]
4. Thioguanine-induced S and G2 blocks and their significance to the mechanism of cytotoxicity.
Wotring LL; Roti Roti JL
Cancer Res; 1980 May; 40(5):1458-62. PubMed ID: 7370984
[TBL] [Abstract][Full Text] [Related]
5. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
6. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
Kim K; Blechman WJ; Riddle VG; Pardee AB
Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006
[TBL] [Abstract][Full Text] [Related]
7. Combined effect of cytosine arabinoside and thiopurines.
Valeriote F; Vietti T; Edelstein M
Cancer Treat Rep; 1976 Dec; 60(12):1925-34. PubMed ID: 1026347
[TBL] [Abstract][Full Text] [Related]
8. Tissue pharmacokinetics, inhibition of DNA synthesis and tumor cell kill after high-dose methotrexate in murine tumor models.
Sirotnak FM; Donsbach RC; Dorick DM; Moccio DM
Cancer Res; 1976 Dec; 36(12):4672-8. PubMed ID: 1000510
[TBL] [Abstract][Full Text] [Related]
9. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
10. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
11. Proposed mechanism of therapeutic selectivity for 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia based upon lower capacities for transport and phosphorylation in proliferative intestinal epithelium compared to tumor cells.
Barrueco JR; Jacobsen DM; Chang CH; Brockman RW; Sirotnak FM
Cancer Res; 1987 Feb; 47(3):700-6. PubMed ID: 3802076
[TBL] [Abstract][Full Text] [Related]
12. Effect of dose, schedule, and route of administration on the in vivo toxicity and antitumor activity of two activated sulfhydryl derivatives of cyclophosphamide.
Ramonas LM; Erickson LC; Ringsdorf H; Zaharko DS
Cancer Res; 1980 Oct; 40(10):3704-8. PubMed ID: 7438053
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of 9-methoxy-N,N-dimethyl-5-nitropyrazolo [3,4, 5-kl]acridine-2(6H)-propanamine (PZA, PD 115934, NSC 366140) in mice: guidelines for early clinical trials1.
Foster BJ; Wiegand RA; LoRusso PM; Baker LH
Clin Cancer Res; 1995 Aug; 1(8):831-7. PubMed ID: 9816052
[TBL] [Abstract][Full Text] [Related]
14. Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy.
Griswold DP; Trader MW; Frei E; Peters WP; Wolpert MK; Laster WR
Cancer Res; 1987 May; 47(9):2323-7. PubMed ID: 3567926
[TBL] [Abstract][Full Text] [Related]
15. Effects of pulse and continuous intravenous infusion of cis-diamminedichloroplatinum on L1210 leukemia in vivo.
Moran RE; Straus MJ
Cancer Res; 1981 Dec; 41(12 Pt 1):4993-6. PubMed ID: 7198009
[TBL] [Abstract][Full Text] [Related]
16. Characterization of tumor cell heterogeneity of a murine leukemia cell line (L1210) in response to arabinosylcytosine: quantitation using a computerized image analysis system.
Raymakers RA; Slocum HK; Minderman H; Malmberg M; Rustum YM
Exp Hematol; 1993 May; 21(5):602-7. PubMed ID: 8513859
[TBL] [Abstract][Full Text] [Related]
17. Effects of aclacinomycin on cell survival and cell cycle progression of cultured mammalian cells.
Traganos F; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
Cancer Res; 1981 Jul; 41(7):2728-37. PubMed ID: 6166368
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo.
Schwock J; Pham NA; Cao MP; Hedley DW
Cancer Chemother Pharmacol; 2008 Apr; 61(4):669-81. PubMed ID: 17579866
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
20. Effects on the monocyte-macrophage system and antitumor activity against L1210 leukemia of cis-bis-cyclopentenecarboxylato-trans-R,R-1,2-diaminocyclohexane -platinum (II) encapsulated in multilamellar vesicles.
Perez-Soler R; Khokhar AR; Claringbold P; Kasi LP; Lopez-Berestein G
J Natl Cancer Inst; 1986 Nov; 77(5):1137-43. PubMed ID: 2430132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
